Brussels, 06/02/2014 (Agence Europe) - Of 81 medicines recommended for marketing by the European Medicines Agency's (EMA) in 2013 a total of 11 were intended for the treatment of rare diseases. This continues the year-on-year increase in the number of marketing authorisation recommendations for medicines for rare diseases observed over the last few years (with 4 in 2011 and 8 in 2012). The EMA says that manufacturers are now beginning to make better use of the instruments provided by the EMA...